Anaphylactoid reactions and late skin reactions to radiocontrast media: The present state of the question;Réactions anaphylactoïdes et cutanées tardives aux produits de contraste iodés: État actuel de la question - Évolution des idées

Revue de Medecine Interne

Volumn 22, Issue 10, 2001, Pages 969-977

  Moneret Vautrin, D A ^a   Kanny, G ^a   Morisset, M ^a   Beaudouin, E ^a   Renaudin, J M ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Anaphylactoid shock; Anaphylaxis; Iodinated contrast media; Late skin reactions; Premedication; Risk factors

Indexed keywords

ADIPIODONE MEGLUMINE; ANTIHISTAMINIC AGENT; CORTICOSTEROID; GADOLINIUM PENTETATE MEGLUMINE; IMMUNOGLOBULIN E; IOBITRIDOL; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; IOVERSOL; IVEPAQUE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; MEGLUMINE IOXITALAMATE PLUS SODIUM IOXITALAMATE; OPTIJECT; TRYPTASE; UNCLASSIFIED DRUG;

AGE; ANAMNESIS; ANAPHYLAXIS; ASTHMA; ATOPY; CARDIOVASCULAR DISEASE; CORTICOSTEROID THERAPY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG USE; ENZYME BLOOD LEVEL; GENDER; HUMAN; IMMUNOHISTOLOGY; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN MANIFESTATION;

EID: 0034776307     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00455-6     Document Type: Short Survey

References (75)

1. Contrast media reactions
2. Anaphylactoid reactions to radiocontrast material
3. Pathophysiology of contrast media anaphylactoid reactions: New perspectives on an old problem
4. Complications des produits de contraste. Conférences d'actualisation 1998
5. Adverse reactions to contrast media: A report from the Committee on Safety of Contrast Media of the International Society of Radiology
6. Adverse reactions to contrast agents. Scope of the problem
7. Anaphylactoid reaction after oral administration of diatrizoate meglumine and diatrizoate sodium solution
8. Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers
9. Drug related fatal anaphylactic shock in Denmark 1968-1990. A study based on notifications to the committee on adverse drug reactions
10. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions
11. The RACR survey of intravenous contrast media reactions: Final report
12. Late allergy-like reactions following vascular administration of radiography contrast media
13. Adverse reactions to ionic and non ionic contrast media: A report from the Japanese Committee on the Safety of Contrast Media
14. Ionic versus non ionic contrast media: A prospective study of the effect of rapid bolus injection on nausea and anaphylactoid reactions
15. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography
16. Low-osmolality contrast agents: Who needs them?
17. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization
18. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to non ionic radiocontrast medium
19. Development of a life-threatening anaphylactoid reaction following administration of ioversol in a child
20. Reports on contrast media reactions: Analysis of data from reports to the US Food and Drug Administration
21. Acute reactions to urographic contrast medium
22. The current status of reactions to intravenous contrast media
23. Contrast media adverse reactions: Occurrence, recurrence and distribution patterns
24. Refractory anaphylactoid shock potentiated by beta-blockers
25. Increased risk for anaphylactic reaction from contrast media in patients on betaadrenergic blockers or with asthma
26. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders
27. Risk of anaphylaxis in patients receiving betablocker drugs
28. Adverse reactions to intravenously administered contrast media
29. Treatment to adverse reaction to radiographic contrast media in adults
30. Patient allergies: Role in selective use of nonionic contrast material
31. How well does a history of seafood allergy predict the likelihood of an material?
32. The role of a documented allergic profile as a risk factor radiographic contrast media reaction
33. Gender risk for anaphylactoid reaction to radiographic contrast media
34. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material
35. Assessment of patients who have experienced anaphylaxis: A 3-years survey
36. Vasopeptidase inhibition and angio-oedema
37. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells
38. Human basophil/mast cell releasability. Heterogeneity of the effects of contrast media on mediator release
39. Jonsson Plasma histamine levels following administration of radiographic contrast media
40. Adverse reactions during intravenous urography: Are these due to histamine release?
41. Mechanisms of severe immediate reactions to iodinated contrast material
42. Anaphylactoid and anaphylactic reactions to iodinated contrast material
43. Detection of IgE antibody to a radiocontrast medium
44. Plasma levels of prekallikrein, alpha2 macroglobulin and Cl esterase inhibitor in patients with urticarial reaction to contrast media
45. Delayed allergy-like reactions to X-ray contrast media
46. Delayed reactions to urographic contrast media
47. Late adverse reactions to nonionic contrast media. A cohort analytic study
48. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media
49. Delayed adverse reactions to nonionic monomeric contrast-enhanced media
50. Multiple fixed drug eruption caused by iomeprol (Iomeron®), a nonionic contrast medium
51. Delayed adverse reaction to sodium ioxaglic acid-meglumine
52. Late-type allergy to the X-ray contrast medium Solutrast® (iopamidol)
53. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium
54. Late skin test reactions to radiocontrast medium
55. Positive skin tests in late reactions to radiographic contrast media
56. Increased incidence of hypersensitivity to iodine containing radiographic contrast media after interleukin 2 administration
57. The administration of radiographic contrast media to patients with a history of a previous reactions
58. An approach to the performance of radiocontrast studies in contrast material-reactive persons
59. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients
60. Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1 and H2 receptor antagonists. Results of a prospective controlled trial
61. Comparison of three pretreatment protocols to prevent anaphylactoid reactions to radiocontrast media
62. Acute reactions to intravascular contrast media: Types, risk factors, recognition, and specific treatment
63. Severe anaphylactoid reaction to radiographic contrast media: Recurrence despite premedication with diphenhydramine and prednisone
64. Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids and nonionic agents
65. Prevention of anaphylactoid reactions in high-risk patients receiving radiographic contrast media
66. Cardiovascular effects of iodinated contrast agents
67. Delayed hypersensitivity reaction to the non-ionic contrast medium iopromid
68. Hypersensitivity reaction to ioversol
69. Allergy and contrast media
70. Chemioembolizzazione epatica in paziente allergico al mezzo di contrasto iodato: Uso del Gd-DTPA
71. Clinical safety of gadopentetate dimeglumine
72. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine
73. Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications
74. Choc anaphylactique induit par le gadotérate de méglumine en IRM
75. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: Evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media